Multicenter Retrospective Study of Isoflurane in Refractory and Super-Refractory Status Epilepticus

To Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ganaxolone Added to Standard of Care in Refractory Status Epilepticus (RSE)

NCT05814523 ·Status: WITHDRAWN ·Phase: PHASE3

REACH: RWE Retrospective Study to Evaluate Cenobamate Impact on Health Care Resource Utilization

NCT06922175 ·Status: RECRUITING

A Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy

NCT02495844 ·Status: COMPLETED ·Phase: PHASE2

Cenobamate in Adults With Focal-Onset Seizures

NCT05859854 ·Status: ACTIVE_NOT_RECRUITING

Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adolescence Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures

NCT03059381 ·Status: COMPLETED

Observational Retrospective Study of Effectivity and Tolerability in Patients With Lacosamide Medication

NCT01858870 ·Status: COMPLETED

Cannabidiol in Children With Refractory Epileptic Encephalopathy

NCT03024827 ·Status: UNKNOWN ·Phase: PHASE1

Stiripentol for the Treatment of Refractory Status Epilepticus

NCT06540378 ·Status: COMPLETED

Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

NCT05067634 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study for the Diagnosis and Treatment of Drug-resistant Focal Epilepsies

NCT06794606 ·Status: RECRUITING

A Study to Evaluate the Safety, Tolerability and Efficacy of Oral Administration of PTL101 (Cannabidiol) as an Adjunctive Treatment for Pediatric Intractable Epilepsy

NCT02987114 ·Status: COMPLETED ·Phase: PHASE2

Exploring the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures

NCT00416195 ·Status: COMPLETED ·Phase: PHASE2

Long-Term Follow-Up of a Cohort of Participants Prescribed Epidyolex in France in a Real-life Setting

NCT05772429 ·Status: ACTIVE_NOT_RECRUITING

Interest of a Specific Care Pathway for the Management of Catamenial Epilepsy

NCT05898152 ·Status: UNKNOWN

Multicentre Real-life Follow-up Study of Rare Epileptic Syndromes in Children and Adolescents

NCT05126914 ·Status: RECRUITING

Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy.

NCT00175864 ·Status: WITHDRAWN ·Phase: PHASE3

Study to Test the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adults With Drug-resistant Epilepsy

NCT03373383 ·Status: COMPLETED ·Phase: PHASE2

A Study Investigating the Anti-epileptic Efficacy of Afinitor (Everolimus) in Patients With Refractory Seizures Who Have Focal Cortical Dysplasia Type II (FCD II)

NCT03198949 ·Status: COMPLETED ·Phase: PHASE2

The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy

NCT07095933 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures

NCT00152451 ·Status: COMPLETED ·Phase: PHASE2

Circulating microRNAs as Biomarkers of RESPIratory Dysfunction in Patients With Refractory epilePSY

NCT03419000 ·Status: COMPLETED ·Phase: NA

A Study to Investigate How Effective, Safe and Tolerable the Drug NBI-921352 is When Used With Anti-seizure Medications in Adults With Focal Onset Seizures

NCT05159908 ·Status: COMPLETED ·Phase: PHASE2

The Benefit and Safety of Older Generation Anti-Epileptic Drugs (AEDs) in Drug-Resistant Epilepsy Children

NCT05697614 ·Status: UNKNOWN ·Phase: PHASE4

Cannabis Extract in Refractory Epilepsy Study

NCT03808935 ·Status: TERMINATED ·Phase: PHASE3

Assessment of Adults Epidemiological Characteristics of Status Epilepticus in the French West Indies and in French Guiana

NCT05246566 ·Status: RECRUITING